Methodology

All entries for: Chiesi Farmaceutici S.p.A.

April 1, 2026

Chiesi Farmaceutici S.p.A.

Designated

treatment of neonatal hypoxic ischemic encephalopathy

Disease Area: Rare Disease
Source
November 25, 2025

Chiesi Farmaceutici S.p.A.

Orphan Drug Designation

FDA orphan drug designation: treatment of idiopathic pulmonary fibrosis

Disease Area: Rare Diseases
Source
Source
Scroll to Top